TableĀ 1

Summarising strategy, physiological effects and disadvantages of IABP, Impella, TandemHeart and VA-ECMO

DeviceMechanismProposed physiology effectsPotential advantagesPotential disadvantages
IABPPhasic (pulsatile) modulation of aortic pressure by displacing aortic blood volumeReduces LV afterload
Augments aortic diastolic pressure
Increases coronary flow during active ischaemia21
Ease of insertion
No need for intracardiac penetration
Contraindicated in aortic regurgitation
Dependent on native contractile function
Inefficient during arrhythmia or marked hypotension
Modest increase in systemic perfusion and LV unloading
Impella recoverLV to ascending aortic continuous flow microaxial flow pump (intracorporeal)Reduce LV pressure and volume (PVA)
Augments systemic mean pressure
Increases coronary flow during active ischaemia22
Ease of insertion
Independent of native contractile function
Contraindicated in presence of LV thrombus and aortic regurgitation
Risk of haemolysis
Bleeding complications
Vascular complications
TandemHeartLeft atrial to descending aortic non-pulsatile flow, extracorporeal pumpReduces LV preload thereby reducing LV volumes (PVA)
Augments systemic mean pressure
Independent of native contractile function
Can be used in the setting of aortic regurgitation23
Bleeding complications
Vascular complications
Requires transseptal puncture
Risk of haemolysis
VA-ECMORight atrial to descending aortic flow, retrograde if peripheral type
Extracorporeal pump with membrane oxygenator
Augments systemic mean pressure
Supplements systemic oxygenation
Independent of native contractile function
Useful for biventricular failure
Bleeding complications
Vascular complications
No change in PVA
Requires LV venting to reduce any increase in LV afterload
Risk of haemolysis
  • AR, aortic regurgitation; IABP, intra-aortic balloon pump; LV, left ventricular; MAP, mean arterial pressure; PVA, pressure volume area; VA-ECMO, veno-arterial extracorporeal membrane oxygenation.